{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:24:44Z","timestamp":1790958284691,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.dld.2024.08.044","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T17:13:24Z","timestamp":1725642804000},"page":"251-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR)"],"prefix":"10.1016","volume":"57","author":[{"given":"Mathurin","family":"Fumery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Altwegg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5846-113X","authenticated-orcid":false,"given":"Philippe","family":"Aygalenq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9rome","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Ghestem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jamonneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Kirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bou\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dld.2024.08.044_bib0001","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.dld.2024.08.044_bib0002","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/ibd\/izy015","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.dld.2024.08.044_bib0003","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/flgastro-2013-100409","article-title":"Disease status, patient quality of life and healthcare resource use for ulcerative colitis in the UK: an observational study","volume":"5","author":"Vaizey","year":"2014","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0004","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12876-020-1164-0","article-title":"The association between disease activity and patient-reported outcomes in patients with moderate-to-severe ulcerative colitis in the United States and Europe","volume":"20","author":"Armuzzi","year":"2020","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"10.1016\/j.dld.2024.08.044_bib0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.dld.2016.01.011","article-title":"Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort study","volume":"48","author":"Van Assche","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2024.08.044_bib0006","unstructured":"HAS. Actes et prestations affection de longue dur\u00e9e N\u00b024 \u2013 Rectocolite h\u00e9morragique \u00e9volutive. Mai 2019. Available from: URL: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2008-06\/lap_rch_web.pdf"},{"key":"10.1016\/j.dld.2024.08.044_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1684\/hpg.2022.2335","article-title":"Recommandations de pratique pour le diagnostic et la prise en charge de la rectocolite h\u00e9morragique (version courte)","volume":"29","author":"Amiot","year":"2022","journal-title":"H\u00e9pato-Gastro et Oncologie Digestive"},{"key":"10.1016\/j.dld.2024.08.044_bib0008","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40271-019-00407-5","article-title":"A qualitative research for defining meaningful attributes for the treatment of inflammatory bowel disease from the patient perspective","volume":"13","author":"Louis","year":"2020","journal-title":"Patient"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0009","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s41687-022-00522-2","article-title":"Psychometric evaluation of the Urgency NRS as a new patient-reported outcome measure for patients with ulcerative colitis","volume":"6","author":"Dubinsky","year":"2022","journal-title":"J Patient Rep Outcomes"},{"issue":"10","key":"10.1016\/j.dld.2024.08.044_bib0010","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.dld.2024.08.044_bib0011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s40273-019-00876-4","article-title":"A French value set for the EQ-5D-5L","volume":"38","author":"Andrade","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"10.1016\/j.dld.2024.08.044_bib0012","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MIB.0000000000001033","article-title":"Development of the IBD disk: a visual self-administered tool for assessing disability in inflammatory bowel diseases","volume":"23","author":"Ghosh","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"10.1016\/j.dld.2024.08.044_bib0013","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.dld.2024.08.044_bib0014","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/apt.16353","article-title":"Determinants of IBD-related disability: a cross-sectional survey from the GETAID","volume":"53","author":"Tannoury","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0015","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s41687-022-00522-2","article-title":"Psychometric evaluation of the Urgency NRS as a new patient-reported outcome measure for patients with ulcerative colitis","volume":"6","author":"Dubinsky","year":"2022","journal-title":"J Patient Rep Outcome"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02050307","article-title":"Etiology and management of fecal incontinence","volume":"36","author":"Jorge","year":"1993","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.dld.2024.08.044_bib0017","unstructured":"ASIP-Sant\u00e9 RPPS, traitements Drees - donn\u00e9es au 1er janvier 2022 Available from: URL: https:\/\/drees.solidarites-sante.gouv.fr\/communique-de-presse\/demographie-des-professionnels-de-sante-au-1er-janvier-2022-revision-la-baisse"},{"issue":"3","key":"10.1016\/j.dld.2024.08.044_bib0018","doi-asserted-by":"crossref","first-page":"otab046","DOI":"10.1093\/crocol\/otab046","article-title":"Prevalence and factors associated with fecal urgency among patients with ulcerative colitis and Crohn's disease in the study of a prospective adult research cohort with inflammatory bowel disease","volume":"3","author":"Dawwas","year":"2021","journal-title":"Crohns Colitis 360"},{"issue":"6","key":"10.1016\/j.dld.2024.08.044_bib0019","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.cgh.2023.02.029","article-title":"Identifying, understanding, and managing fecal urgency in inflammatory bowel diseases","volume":"21","author":"Caron","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.044_bib0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s41687-018-0049-2","article-title":"Development and validation of the ulcerative colitis patient-reported outcomes signs and symptoms (UC-pro\/SS) diary","volume":"2","author":"Higgins","year":"2017","journal-title":"J Patient Rep Outcomes"},{"issue":"11","key":"10.1016\/j.dld.2024.08.044_bib0021","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.14309\/ajg.0000000000002404","article-title":"Bowel urgency in ulcerative colitis: current perspectives and future directions","volume":"118","author":"Dubinsky","year":"2023","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41687-022-00439-w","article-title":"Incorporating patient experience into drug development for ulcerative colitis: development of the Urgency Numeric Rating Scale, a patient-reported outcome measure to assess bowel urgency in adults","volume":"6","author":"Dubinsky","year":"2022","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.dld.2024.08.044_bib0023","first-page":"izad142","article-title":"The communicating needs and features of IBD experiences (CONFIDE) study: US and European patient and health care professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis","author":"Travis","year":"2023","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"10.1016\/j.dld.2024.08.044_bib0024","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.dld.2022.01.125","article-title":"Faecal incontinence in inflammatory bowel disease: the Nancy experience","volume":"54","author":"Kurt","year":"2022","journal-title":"Dig Liver Dis"},{"issue":"1","key":"10.1016\/j.dld.2024.08.044_bib0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/apt.17502","article-title":"The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: a cross-sectional study","volume":"58","author":"Vasant","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.dld.2024.08.044_bib0026","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/apt.16353","article-title":"GETAID-patient experience study group. determinants of IBD-related disability: a cross-sectional survey from the GETAID","volume":"53","author":"Tannoury","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.dld.2024.08.044_bib0027","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/ecco-jcc\/jjz035","article-title":"Perceived quality of care is associated with disease activity, quality of life, work productivity, and gender, but not disease phenotype: a prospective study in a high-volume IBD centre","volume":"13","author":"Gonczi","year":"2019","journal-title":"J Crohns Colitis"},{"issue":"12","key":"10.1016\/j.dld.2024.08.044_bib0028","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S2468-1253(20)30300-9","article-title":"Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis","volume":"5","author":"Fairbrass","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T01:50:16Z","timestamp":1735782616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824009630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1590865824009630"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.044","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease burden of patients with moderate to severe ulcerative colitis: A French multicenter real-life study (THEFAR)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}